Last 12 months
Inside the activity.
5 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 2 | 0 |
| Jun 2026 | 3 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2017 Filed Nov 2, 2017 20:34 UTC |
Herren Richard ScottChief Financial Officer
|
Tax withholdingCommon Stock | 6,262 | $124.78 | $781,372.36 |
DisclosureSEC source: 0001209191-17-058872 · doc4.xml · nonDerivative · entry 1 Herren Richard Scott · CIK 0001340472 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,650 F1 · kind: Shares withheld to cover taxes. F2 · balance_after: Includes shares acquired in September 2017 pursuant to the Issuer's Employee Stock Purchase Plan. F3 · balance_after: The total securities beneficially owned includes 51,753 shares of unvested Restricted Stock Units. Read SEC document |
| October 31, 2017 Filed Nov 1, 2017 20:08 UTC |
Di Fronzo Pascal WSVP, Corp Affairs, CLO & Sec
|
SaleCommon Stock | 19,577 | $125.00 | $2,447,125.00 |
DisclosureSEC source: 0001209191-17-058588 · doc4.xml · nonDerivative · entry 1 Di Fronzo Pascal W · CIK 0001394844 · SVP, Corp Affairs, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,469 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/30/2017. F2 · balance_after: The total securities beneficially owned includes 39,890 shares of unvested Restricted Stock Units. Read SEC document |
| October 15, 2017 Filed Oct 17, 2017 20:27 UTC |
BASS CARLDirector
|
GiftCommon Stock | 35,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-057155 · doc4.xml · nonDerivative · entry 1 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| October 09, 2017 Filed Oct 10, 2017 21:29 UTC |
BECKER JANSVP, CHRO and Corp Real Estate
|
Tax withholdingCommon Stock | 17,772 | $117.14 | $2,081,812.08 |
DisclosureSEC source: 0001209191-17-056498 · doc4.xml · nonDerivative · entry 1 BECKER JAN · CIK 0001221135 · SVP, CHRO and Corp Real Estate 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,707 F1 · kind: Shares withheld to cover taxes. F2 · shares: Pursuant to the terms of the September 30, 2017 agreement between the Reporting Person and the Company, certain of the Reporting Person's Restricted Stock Units accelerated and vested on October 9, 2017. The balance of the Reporting Person's Restricted Stock Units were cancelled. F3 · balance_after: Includes shares acquired in September 2017 pursuant to the Issuer's Employee Stock Purchase Plan. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 20:04 UTC |
Di Fronzo Pascal WSVP, Corp Affairs, CLO & Sec
|
SaleCommon Stock | 580 | $110.91 | $64,327.80 |
DisclosureSEC source: 0001209191-17-055745 · doc4.xml · nonDerivative · entry 1 Di Fronzo Pascal W · CIK 0001394844 · SVP, Corp Affairs, CLO & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,046 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/30/2017. F2 · balance_after: Includes shares acquired in September 2017 pursuant to the Issuer's Employee Stock Purchase Plan. F3 · balance_after: The total securities beneficially owned includes 39,890 shares of unvested Restricted Stock Units. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 21:11 UTC |
NORRINGTON LORRIE MDirector
|
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $43.81 | $0.00 |
DisclosureSEC source: 0001209191-17-054429 · doc4.xml · derivative · entry 4 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2018-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The option vests over a three-year period beginning on 3/24/2011, at the rate of 17,000 shares on the first anniversary, and 16,500 shares on the second and third anniversaries. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 21:11 UTC |
NORRINGTON LORRIE MDirector
|
SaleCommon Stock | 896 | $111.74 | $100,120.65 |
DisclosureSEC source: 0001209191-17-054429 · doc4.xml · nonDerivative · entry 3 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,492 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/30/2017. F4 · price: Shares were sold in various amounts from $111.59 to $111.95 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 21:11 UTC |
NORRINGTON LORRIE MDirector
|
SaleCommon Stock | 24,104 | $111.10 | $2,677,848.34 |
DisclosureSEC source: 0001209191-17-054429 · doc4.xml · nonDerivative · entry 2 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,388 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/30/2017. F3 · price: Shares were sold in various amounts from $110.56 to $111.55 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| September 28, 2017 Filed Sep 29, 2017 21:11 UTC |
NORRINGTON LORRIE MDirector
|
Exercise / conversionCommon Stock | 25,000 | $43.81 | $1,095,250.00 |
DisclosureSEC source: 0001209191-17-054429 · doc4.xml · nonDerivative · entry 1 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 00:41 UTC |
Blum Steven MSVP, Worldwide Sales
|
SaleCommon Stock | 200 | $112.72 | $22,543.00 |
DisclosureSEC source: 0001209191-17-053892 · doc4.xml · nonDerivative · entry 2 Blum Steven M · CIK 0001515843 · SVP, Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,691 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/21/16. F4 · price: Shares were sold in various amounts from $112.68 to $112.75 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 51,366 shares of unvested Restricted Stock Units. Read SEC document |
| September 22, 2017 Filed Sep 26, 2017 00:41 UTC |
Blum Steven MSVP, Worldwide Sales
|
SaleCommon Stock | 8,928 | $112.25 | $1,002,134.07 |
DisclosureSEC source: 0001209191-17-053892 · doc4.xml · nonDerivative · entry 1 Blum Steven M · CIK 0001515843 · SVP, Worldwide Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,891 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 12/21/16. F2 · price: Shares were sold in various amounts from $111.68 to $112.66 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 51,366 shares of unvested Restricted Stock Units. Read SEC document |
| September 21, 2017 Filed Sep 22, 2017 20:10 UTC |
BEVERIDGE CRAWFORD WDirector
|
SaleCommon Stock | 1,500 | $112.82 | $169,230.00 |
DisclosureSEC source: 0001209191-17-053694 · doc4.xml · nonDerivative · entry 1 BEVERIDGE CRAWFORD W · CIK 0001220056 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 29,171 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 6/21/17. F2 · balance_after: The total securities beneficially owned includes 3,935 shares of unvested Restricted Stock Units. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 20:14 UTC |
Anagnost AndrewDirector · President and CEO
|
SaleCommon Stock | 1,413 | $114.73 | $162,113.07 |
DisclosureSEC source: 0001209191-17-050558 · doc4.xml · nonDerivative · entry 3 Anagnost Andrew · CIK 0001661768 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,746 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/06/2017. F5 · price: Shares were sold in various amounts from $114.5001 to $115.14 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 92,155 shares of unvested Restricted Stock Units. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 20:14 UTC |
Anagnost AndrewDirector · President and CEO
|
SaleCommon Stock | 3,157 | $113.19 | $357,334.52 |
DisclosureSEC source: 0001209191-17-050558 · doc4.xml · nonDerivative · entry 2 Anagnost Andrew · CIK 0001661768 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 122,159 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/06/2017. F4 · price: Shares were sold in various amounts from $113 to $113.50 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 92,155 shares of unvested Restricted Stock Units. Read SEC document |
| August 28, 2017 Filed Aug 29, 2017 20:14 UTC |
Anagnost AndrewDirector · President and CEO
|
SaleCommon Stock | 19,434 | $112.50 | $2,186,410.51 |
DisclosureSEC source: 0001209191-17-050558 · doc4.xml · nonDerivative · entry 1 Anagnost Andrew · CIK 0001661768 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,316 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 03/06/2017. F2 · price: Shares were sold in various amounts from $112 to $112.99 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 92,155 shares of unvested Restricted Stock Units. Read SEC document |
| July 19, 2017 Filed Jul 21, 2017 20:04 UTC |
FRENCH R REID JRDirector
|
GrantCommon Stock | 2,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-045914 · doc4.xml · nonDerivative · entry 1 FRENCH R REID JR · CIK 0001267013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,037 F1 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted automatically under the 2012 Outside Directors' Stock Plan, vest on the date of the next annual meeting. F2 · balance_after: The total securities beneficially owned includes 2,037 shares of unvested Restricted Stock Units. Read SEC document |
| July 19, 2017 Filed Apr 16, 2018 20:26 UTC Amendment |
FRENCH R REID JRDirector
|
GrantCommon Stock | 2,037 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-024994 · doc4a.xml · nonDerivative · entry 1 FRENCH R REID JR · CIK 0001267013 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,037 F1 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted automatically under the 2012 Outside Directors' Stock Plan, vest on the date of the next annual meeting. F2 · balance_after: The total securities beneficially owned includes 2,037 shares of unvested Restricted Stock Units. Read SEC document |
| July 10, 2017 Filed Jul 11, 2017 20:10 UTC |
Hanspal AmarpreetSVP & Chief Product Officer
|
Tax withholdingCommon Stock | 31,256 | $103.74 | $3,242,497.44 |
DisclosureSEC source: 0001209191-17-044768 · doc4.xml · nonDerivative · entry 1 Hanspal Amarpreet · CIK 0001394887 · SVP & Chief Product Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,799 F1 · kind: Shares withheld to cover taxes. F2 · shares: Pursuant to the terms of the June 18, 2017 Separation Agreement between the Reporting Person and the Company, a portion of the Reporting Person's outstanding Restricted Stock Units accelerated and vested on July 10, 2017. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:04 UTC |
BASS CARLDirector
|
SaleCommon Stock | 7,200 | $102.09 | $735,032.88 |
DisclosureSEC source: 0001209191-17-044364 · doc4.xml · nonDerivative · entry 4 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,289 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F6 · price: Shares were sold in various amounts from $101.95 to $102.29 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| July 06, 2017 Filed Jul 7, 2017 20:04 UTC |
BASS CARLDirector
|
SaleCommon Stock | 6,176 | $101.49 | $626,773.83 |
DisclosureSEC source: 0001209191-17-044364 · doc4.xml · nonDerivative · entry 3 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,489 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F5 · price: Shares were sold in various amounts from $100.92 to $101.895 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:04 UTC |
BASS CARLDirector
|
SaleCommon Stock | 2,200 | $100.58 | $221,272.92 |
DisclosureSEC source: 0001209191-17-044364 · doc4.xml · nonDerivative · entry 2 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,665 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F4 · price: Shares were sold in various amounts from $100.35 to $100.82 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| July 05, 2017 Filed Jul 7, 2017 20:04 UTC |
BASS CARLDirector
|
SaleCommon Stock | 11,177 | $99.83 | $1,115,788.73 |
DisclosureSEC source: 0001209191-17-044364 · doc4.xml · nonDerivative · entry 1 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,865 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F2 · price: Shares were sold in various amounts from $99.30 to $100.28 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 20:20 UTC |
BASS CARLDirector
|
SaleCommon Stock | 18,782 | $102.17 | $1,918,940.04 |
DisclosureSEC source: 0001209191-17-042832 · doc4.xml · nonDerivative · entry 2 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,042 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F4 · price: Shares were sold in various amounts from $102.03 to $102.32 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 30, 2017 Filed Jul 3, 2017 20:20 UTC |
BASS CARLDirector
|
SaleCommon Stock | 23,515 | $101.36 | $2,383,447.48 |
DisclosureSEC source: 0001209191-17-042832 · doc4.xml · nonDerivative · entry 1 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,824 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F2 · price: Shares were sold in various amounts from $101.00 to $101.995 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:48 UTC |
Smith Stacy JDirector
|
Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $34.70 | $0.00 |
DisclosureSEC source: 0001209191-17-042553 · doc4.xml · derivative · entry 6 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 50,000 shares Expires 2018-11-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests over a three-year period beginning on 11/07/2011, at the rate of 17,000 shares on the first anniversary, and 16,500 shares on the second and third anniversaries. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:48 UTC |
Smith Stacy JDirector
|
SaleCommon Stock | 596 | $103.57 | $61,727.72 |
DisclosureSEC source: 0001209191-17-042553 · doc4.xml · nonDerivative · entry 5 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,218 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:48 UTC |
Smith Stacy JDirector
|
SaleCommon Stock | 13,804 | $102.47 | $1,414,461.37 |
DisclosureSEC source: 0001209191-17-042553 · doc4.xml · nonDerivative · entry 4 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,814 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F5 · price: Shares were sold in various amounts from $102.25 to $102.93 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:48 UTC |
Smith Stacy JDirector
|
SaleCommon Stock | 23,000 | $101.66 | $2,338,099.50 |
DisclosureSEC source: 0001209191-17-042553 · doc4.xml · nonDerivative · entry 3 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,618 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F4 · price: Shares were sold in various amounts from $101.25 to $102.24 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:48 UTC |
Smith Stacy JDirector
|
SaleCommon Stock | 12,600 | $100.92 | $1,271,641.14 |
DisclosureSEC source: 0001209191-17-042553 · doc4.xml · nonDerivative · entry 2 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,618 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F3 · price: Shares were sold in various amounts from $100.25 to $101.24 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:48 UTC |
Smith Stacy JDirector
|
Exercise / conversionCommon Stock | 50,000 | $34.70 | $1,735,000.00 |
DisclosureSEC source: 0001209191-17-042553 · doc4.xml · nonDerivative · entry 1 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,218 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:46 UTC |
NORRINGTON LORRIE MDirector
|
Exercise / conversionNon-Qualified Stock Options (right to buy) · Derivative | 25,000 | $0.00 Strike: $43.81 | $0.00 |
DisclosureSEC source: 0001209191-17-042550 · doc4.xml · derivative · entry 6 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2018-03-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option vests over a three-year period beginning on 3/24/2011, at the rate of 17,000 shares on the first anniversary, and 16,500 shares on the second and third anniversaries. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:46 UTC |
NORRINGTON LORRIE MDirector
|
SaleCommon Stock | 298 | $103.57 | $30,863.86 |
DisclosureSEC source: 0001209191-17-042550 · doc4.xml · nonDerivative · entry 5 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,492 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:46 UTC |
NORRINGTON LORRIE MDirector
|
SaleCommon Stock | 5,302 | $102.52 | $543,544.07 |
DisclosureSEC source: 0001209191-17-042550 · doc4.xml · nonDerivative · entry 4 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,790 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F5 · price: Shares were sold in various amounts from $102.29 to $102.93 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:46 UTC |
NORRINGTON LORRIE MDirector
|
SaleCommon Stock | 12,400 | $101.76 | $1,261,843.84 |
DisclosureSEC source: 0001209191-17-042550 · doc4.xml · nonDerivative · entry 3 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,092 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F4 · price: Shares were sold in various amounts from $101.29 to $102.28 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:46 UTC |
NORRINGTON LORRIE MDirector
|
SaleCommon Stock | 7,000 | $100.95 | $706,656.30 |
DisclosureSEC source: 0001209191-17-042550 · doc4.xml · nonDerivative · entry 2 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,492 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F3 · price: Shares were sold in various amounts from $100.29 to $101.28 inclusive. The price listed here reflects the average weighted price. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:46 UTC |
NORRINGTON LORRIE MDirector
|
Exercise / conversionCommon Stock | 25,000 | $43.81 | $1,095,250.00 |
DisclosureSEC source: 0001209191-17-042550 · doc4.xml · nonDerivative · entry 1 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,492 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:29 UTC |
BASS CARLDirector
|
SaleCommon Stock | 324 | $103.57 | $33,556.68 |
DisclosureSEC source: 0001209191-17-042526 · doc4.xml · nonDerivative · entry 4 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,339 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F4 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:29 UTC |
BASS CARLDirector
|
SaleCommon Stock | 5,277 | $102.57 | $541,265.06 |
DisclosureSEC source: 0001209191-17-042526 · doc4.xml · nonDerivative · entry 3 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,663 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F6 · price: Shares were sold in various amounts from $102.34 to $102.86 inclusive. The price listed here reflects the average weighted price. F4 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:29 UTC |
BASS CARLDirector
|
SaleCommon Stock | 12,999 | $101.81 | $1,323,490.59 |
DisclosureSEC source: 0001209191-17-042526 · doc4.xml · nonDerivative · entry 2 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 119,940 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F5 · price: Shares were sold in various amounts from $101.34 to $102.33 inclusive. The price listed here reflects the average weighted price. F4 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 29, 2017 Filed Jun 30, 2017 20:29 UTC |
BASS CARLDirector
|
SaleCommon Stock | 8,601 | $101.00 | $868,716.48 |
DisclosureSEC source: 0001209191-17-042526 · doc4.xml · nonDerivative · entry 1 BASS CARL · CIK 0001221137 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,939 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/31/2017. F2 · price: Shares were sold in various amounts from $100.34 to $101.32 inclusive. The price listed here reflects the average weighted price. F3 · balance_after: Includes shares acquired in March 2017 pursuant to the Issuer's Employee Stock Purchase Plan. F4 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 27, 2017 Filed Jun 28, 2017 20:21 UTC |
RAFAEL BETSYDirector
|
SaleCommon Stock | 2,354 | $106.24 | $250,096.26 |
DisclosureSEC source: 0001209191-17-042121 · doc4.xml · nonDerivative · entry 1 RAFAEL BETSY · CIK 0001255995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 19, 2017 Filed Jun 20, 2017 20:02 UTC |
Anagnost AndrewDirector · President and CEO
|
GrantCommon Stock | 14,487 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-041056 · doc4.xml · nonDerivative · entry 1 Anagnost Andrew · CIK 0001661768 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 144,750 F1 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units vest as to approximately 1/3 of the total shares on an approximate annual basis over a 3-year period from the date of grant on June 19, 2017. F2 · balance_after: The total securities beneficially owned includes 92,155 shares of unvested Restricted Stock Units. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 22:34 UTC |
Ferguson Scott D.Director · See Remarks
Sachem Head Master LPSee Remarks
Uncas GP LLCSee Remarks
Sachem Head GP LLCSee Remarks
|
GrantCommon Stock | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001801 · form410692002_06162017.xml · nonDerivative · entry 2 Ferguson Scott D. · CIK 0001658919 · Director · See Remarks Sachem Head Master LP · CIK 0001658920 · See Remarks Uncas GP LLC · CIK 0001658906 · See Remarks Sachem Head GP LLC · CIK 0001658917 · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,243 F2 · shares: Mr. Ferguson is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted in lieu of Mr. Ferguson's annual fee retainer, vest on the date of the next annual meeting. F4 · balance_after: The total securities beneficially owned includes 8,562 shares of unvested Restricted Stock Units. In addition to the 11,243 shares of Common Stock owned directly by Mr. Ferguson, Mr. Ferguson as managing partner of Sachem Head and the managing member of each of Uncas GP LLC ("Uncas") and Sachem Head GP LLC ("Sachem Head GP"), may be deemed to beneficially own 12,890,000 shares of Common Stock owned in the aggregate by certain affiliated investment funds of Sachem Head, Uncas and Sachem Head GP. Accordingly, the total ownership, in the aggregate, Mr. Ferguson may be deemed to beneficially own is 12,901,243 shares of Common Stock. F3 · ownership.direct: Pursuant to an arrangement between Mr. Ferguson and Sachem Head Capital Management LP ("Sachem Head"), the restricted stock units are held by Mr. Ferguson for the benefit of Sachem Head. Such units are included as directly beneficially owned by Mr. Ferguson, but may also be deemed to be beneficially owned by Sachem Head as a result of such arrangements. Each of the Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 22:34 UTC |
Ferguson Scott D.Director · See Remarks
Sachem Head Master LPSee Remarks
Uncas GP LLCSee Remarks
Sachem Head GP LLCSee Remarks
|
GrantCommon Stock | 2,354 | $0.00 | $0.00 |
DisclosureSEC source: 0000921895-17-001801 · form410692002_06162017.xml · nonDerivative · entry 1 Ferguson Scott D. · CIK 0001658919 · Director · See Remarks Sachem Head Master LP · CIK 0001658920 · See Remarks Uncas GP LLC · CIK 0001658906 · See Remarks Sachem Head GP LLC · CIK 0001658917 · See Remarks Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,396 F1 · shares: Mr. Ferguson is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted annually under the 2012 Outside Directors' Stock Plan, vest on the date of the next annual meeting. F4 · balance_after: The total securities beneficially owned includes 8,562 shares of unvested Restricted Stock Units. In addition to the 11,243 shares of Common Stock owned directly by Mr. Ferguson, Mr. Ferguson as managing partner of Sachem Head and the managing member of each of Uncas GP LLC ("Uncas") and Sachem Head GP LLC ("Sachem Head GP"), may be deemed to beneficially own 12,890,000 shares of Common Stock owned in the aggregate by certain affiliated investment funds of Sachem Head, Uncas and Sachem Head GP. Accordingly, the total ownership, in the aggregate, Mr. Ferguson may be deemed to beneficially own is 12,901,243 shares of Common Stock. F3 · ownership.direct: Pursuant to an arrangement between Mr. Ferguson and Sachem Head Capital Management LP ("Sachem Head"), the restricted stock units are held by Mr. Ferguson for the benefit of Sachem Head. Such units are included as directly beneficially owned by Mr. Ferguson, but may also be deemed to be beneficially owned by Sachem Head as a result of such arrangements. Each of the Reporting Persons disclaims beneficial ownership of the reported securities except to the extent of his or its pecuniary interest therein. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:18 UTC |
Smith Stacy JDirector
|
GrantCommon Stock | 2,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040501 · doc4.xml · nonDerivative · entry 2 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,218 F3 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted annually under the 2012 Outside Directors' Stock Plan, vest on the date of the next annual meeting. F4 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:18 UTC |
Smith Stacy JDirector
|
GrantCommon Stock | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040501 · doc4.xml · nonDerivative · entry 1 Smith Stacy J · CIK 0001415529 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,864 F1 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These are Restricted Stock Units granted under the 2012 Outside Directors' Stock Plan in lieu of cash compensation for services as a director, and vest on the date of the next annual meeting. F2 · balance_after: The total securities beneficially owned includes 847 shares of unvested Restricted Stock Units. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:17 UTC |
RAFAEL BETSYDirector
|
GrantCommon Stock | 2,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040495 · doc4.xml · nonDerivative · entry 1 RAFAEL BETSY · CIK 0001255995 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,354 F1 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted annually under the 2012 Outside Directors' Stock Plan, vest on the date of the next annual meeting. F2 · balance_after: The total securities beneficially owned includes 2,354 shares of unvested Restricted Stock Units. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:15 UTC |
NORRINGTON LORRIE MDirector
|
GrantCommon Stock | 2,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040490 · doc4.xml · nonDerivative · entry 2 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,492 F3 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted annually under the 2012 Outside Directors' Stock Plan, vest on the date of the next annual meeting. F4 · balance_after: The total securities beneficially owned includes 3,201 shares of unvested Restricted Stock Units. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:15 UTC |
NORRINGTON LORRIE MDirector
|
GrantCommon Stock | 847 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040490 · doc4.xml · nonDerivative · entry 1 NORRINGTON LORRIE M · CIK 0001188898 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,138 F1 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These are Restricted Stock Units granted under the 2012 Outside Directors' Stock Plan in lieu of cash compensation for services as a director, and vest on the date of the next annual meeting. F2 · balance_after: The total securities beneficially owned includes 847 shares of unvested Restricted Stock Units. Read SEC document |
| June 14, 2017 Filed Jun 16, 2017 20:14 UTC |
MCDOWELL MARY TDirector
|
GrantCommon Stock | 2,354 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-040481 · doc4.xml · nonDerivative · entry 2 MCDOWELL MARY T · CIK 0001114488 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,116 F3 · kind: The Reporting Person is entitled to receive one share of Common Stock for each Restricted Stock Unit. These Restricted Stock Units, which are granted annually under the 2012 Outside Directors' Stock Plan, vest on the date of the next annual meeting. F4 · balance_after: The total securities beneficially owned includes 3,427 shares of unvested Restricted Stock Units. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.